Scholars Central

Conference abstractPublished 25 Oct 2022

Modes of action of anti HIV RT drugs: Challenges and strategies in chemotherapy

Authors: Bechan Sharma

University of Allahabad, India

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Different combinations of on-going antiretroviral drugs for the treatment of Human Immunodeficiency Virus (HIV) infection have been found to successfully maintain long-term suppression of HIV-1 replication in blood plasma thereby dramatically reducing the viral load to below the limits of viral detection by using the most sensitive clinical assays (<50RNA copies/ ml) resulting in a significant reconstitution of host immune system. Though, none of these therapies is capable of completing eradicating the virus from the long-lived cellular reservoir such as monocyte-derived macrophages (MDM) that poses stumbling blockade to HIV therapy and cure. MDM are widely distributed in all tissues and organs, including central system nervous (CNS) where they represent the most frequent HIV-infected cells. The present FDAapproved 24 antiretroviral drugs used to treat HIV-1 infected individuals mostly target viral reverse transcriptase (HIV-1RT), protease, integrase, and entry processes (coreceptor or fusion blockade) in different combinations. These drugs exert mild to severe toxicity in the patients. It is therefore required to continue efforts to develop some new antiretrovirals targeting alternative steps in the virus lifecycle for further optimizing the therapeutic options, overcoming drug resistance, and contributing potentially to eliminate the of viruses from their cellular reservoirs. This presentation includes an updated account on these issues including the novel strategies being developed to address challenges in this context.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Developing Drugs.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Developing Drugs
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Bechan Sharma”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels